Status:
COMPLETED
Continuous Central Venous Lactate Monitoring by Intravascular Microdialysis : a Comparison to Sequential Arterial Lactate Measurement During Shock.
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Shock
Eligibility:
All Genders
18-99 years
Brief Summary
During shock, arterial hypotension, inadequate cardiac output and microcirculatory alterations lead to tissue hypoxia, multiple organ failure and death. Arterial lactate is considered as the best mark...
Eligibility Criteria
Inclusion
- Acute circulatory failure defined as : systolic blood pressure\<90mmHg or mean arterial pressure \<65mmHg and blood lactate \> 2mmol/L
Exclusion
- Pregnant women
Key Trial Info
Start Date :
February 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2018
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03464747
Start Date
February 17 2017
End Date
June 15 2018
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, France, 30029